Literature DB >> 17955982

Microbiological assay for ceftazidime injection.

Andréia De Haro Moreno1, Hérida Regina Nunes Salgado.   

Abstract

A simple, sensitive, and specific biodiffusion assay for the antibacterial ceftazidime was developed using a strain of Staphylococcus epidermidis (ATCC 12228) as the test organism. Ceftazidime was measured in powder for injection at concentrations ranging from 100 to 400 microg/mL. The calibration graph for ceftazidime was linear (r2 = 1), and the method validation showed that it was precise (relative standard deviation = 0.415) and accurate. The results obtained by biodiffusion assay were statistically calculated by linear parallel model and by means of regression analysis and were verified using analysis of variance. It was concluded that the microbiological assay is satisfactory for in vitro quantification of the antibacterial activity of ceftazidime in pharmaceuticals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17955982

Source DB:  PubMed          Journal:  J AOAC Int        ISSN: 1060-3271            Impact factor:   1.913


  4 in total

1.  Rapid Turbidimetric Assay to Determine the Potency of Daptomycin in Lyophilized Powder.

Authors:  Eliane Gandolpho Tótoli; Hérida Regina Nunes Salgado
Journal:  Pharmaceutics       Date:  2015-07-09       Impact factor: 6.321

2.  Development and validation of a microbiological agar assay for determination of orbifloxacin in pharmaceutical preparations.

Authors:  Edith C L Cazedey; Hérida R N Salgado
Journal:  Pharmaceutics       Date:  2011-08-29       Impact factor: 6.321

3.  Development and validation of a rapid turbidimetric assay to determine the potency of cefuroxime sodium in powder for dissolution for injection.

Authors:  Daniela C M Vieira; Thalita F M Fiuza; Hérida R N Salgado
Journal:  Pathogens       Date:  2014-07-30

4.  Development and validation of a successful microbiological agar assay for determination of ceftriaxone sodium in powder for injectable solution.

Authors:  Patrícia V Aléssio; Hérida R N Salgado
Journal:  Pharmaceutics       Date:  2012-06-29       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.